[Genitourinary Oncology Committee of Chinese Anti-Cancer Association (CACA-GO) guideline for prostate cancer for patients (2025 edition)].

Prostate cancer is a relatively common malignant tumor in the genitourinary system of elderly men, posing a heavy burden to the public health. In order to disseminate the knowledge of early screening and diagnosis of prostate cancer, effectively promote the prevention and treatment of prostate cancer in China, and improve patients' cognition of prostate cancer,the Genitourinary Oncology Committee of Chinese Anti-Cancer Association organized a panel of experts to formulate the "Genitourinary Oncology Committee of China Anti-Cancer Association (CACA-GO) guideline for prostate cancer for patients (2025 edition)", with the aim of enhancing the understanding of prostate cancer diagnosis and treatment among patients and their families, assisting clinicians in more effectively conducting prostate cancer diagnosis and treatment, thereby improving patients' survival outcomes and quality of life, benefiting more prostate cancer patients, and contributing to the grand goal of "Healthy China 2030".